Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BDSX
#3389
Biodesix, Inc. Common Stock
14.760
0
USD
+1.79%
Sector:
Atención Sanitaria
Básica:
USD
Profit Currency:
USD
Rango diario
Rango anual
Cambio diario
+1.79%
Monthly Change
+1.64%
6 month change
+17.99%
Cambio anual
+17.99%
Cierres anteriores
14.500
0
Open
14.760
0
Bid
Ask
Low
14.760
0
High
14.760
0
Volumen
8
Markets
Acciones
Atención Sanitaria
BDSX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
1.33 M
1.57 M
3.9 M
4.85 M
7.3 M
9.86 M
—
Valuation ratios
Enterprise value
-35.34 M
-24.42 M
-35.1 M
-17.66 M
-15.03 M
48.05 M
59.83 M
Price to earnings ratio
—
—
-0.07
-0.14
-0.23
-1.46
-3.09
Price to sales ratio
—
—
0.11
0.15
0.14
0.58
1.33
Price to cash flow ratio
—
—
-0.1
-0.32
-0.2
-2.21
-4.29
Price to book ratio
—
—
0.21
1.6
0.48
-20.83
-19.14
Enterprise value to EBITDA ratio
—
—
0.71
0.45
0.45
-1.84
-2.32
Profitability ratios
Return on assets %
0.26
0.57
0.7
0.53
0.44
0.4
0.4
Return on equity %
0.76
2.19
3.18
11.39
2.06
14.31
17.76
Return on invested capital %
182.37
319.78
386.81
245.54
194.34
188.81
188.54
Gross margin %
100
100
97.64
99.59
98.73
99.74
399.15
Operating margin %
50.34
75.11
132.39
84.22
48.37
31.5
138.66
EBITDA margin %
—
—
-129.57
-80.59
-46.83
-29.46
-111.23
Net margin %
68.81
79.18
171.27
106.23
60.19
39.85
172.99
Liquidity ratios
Quick ratio
—
—
2.34
1.19
—
—
—
Current ratio
2.68
1.51
2.34
1.19
2.76
1.86
8.07
Inventory turnover
—
—
-9
-2
—
—
—
Asset turnover
0.38
0.55
0.45
0.51
0.73
0.96
1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.13
0.13
0.27
0.36
0.37
0.54
2.03
Long term debt to total equity ratio
0.39
0.51
1.21
7.69
1.74
19.25
91.03
Per share metrics
Operating cash flow per share
—
—
21.36
5.57
7.5
3.08
3.15
EBIT per share
—
—
-24.46
-10.12
-5.46
-3.72
-3.8
EBITDA per share
—
—
-23.52
-9.64
-5.15
-3.45
-2.96
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
20.47
6.4
4.04
2.51
9.96
Net current asset value per share
—
—
25.34
9.67
6.09
4.31
17.23
Tangible book value per share
—
—
-2.01
-4.47
-0
-2.18
-8.37
Working capital per share
—
—
14.49
1.53
3.88
2
8.61
Book value per share
—
—
9.79
1.12
3.22
0.33
2.22
Noticias
Biodesix publica estudio de validación de biomarcador de nódulos pulmonares
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
Here's Why Investors Continue to Hold Pediatrix Medical Stock
Biodesix en la Conferencia TD Cowen: Expansión en Diagnósticos Pulmonares
Biodesix en Conferencia TD Cowen: Expansión en Diagnósticos Pulmonares
Biodesix at TD Cowen Conference: Lung Diagnostics Expansion
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet
Are Medical Stocks Lagging Biodesix (BDSX) This Year?
Canaccord reitera calificación de Biodesix tras sólidos resultados del 4T
Canaccord reiterates Biodesix stock rating on strong Q4 results
3 Best Stocks to Buy Today with 125%+ Upside, 2/27/2026, According to Top Analysts - TipRanks.com
William Blair mejora la calificación de las acciones de Biodesix por impulso en la ejecución